Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds' portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm from smart money lately.
Cytokinetics Inc (CYTK)
Market is closed
News
- First
- << Previous
- 61 - 68
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
In the financial world, there are plenty of metrics shareholders can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading movement.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
In the eyes of most shareholders, hedge funds are seen as underperforming, outdated investment tools of the past.
Amgen, Inc. (AMGN), Cytokinetics, Inc. (CYTK): A New Approach to Treating a Broken Heart
A failing heart is a lot like a glass Heinz Ketchup bottle. Squeezing the bottle isn't very efficient, so you smack that strategically placed '57,' and still no condiment. So you smack harder, and...
Hedge Funds Aren't Crazy About Cytokinetics, Inc. (CYTK) Anymore
In today’s marketplace, there are a multitude of indicators market participants can use to analyze their holdings. A pair of the most useful are hedge fund and insider trading sentiment.
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
In the eyes of most stock holders, hedge funds are assumed to be slow, old investment tools of yesteryear.
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
If you'd ask most traders, hedge funds are seen as unimportant, old financial tools of yesteryear.
Zynga Inc (ZNGA), Cytokinetics, Inc. (CYTK), and More: 3 Stocks That Blew the Market Away
Every week, I take a look at three companies that beat market expectations, since I believe that it's the biggest factor in a stock beating the market.
- First
- << Previous
- 61 - 68
Billionaire Hedge Funds
